Genomic Valley Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Genomic Valley Biotech has a total shareholder equity of ₹38.2M and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹41.6M and ₹3.4M respectively. Genomic Valley Biotech's EBIT is ₹2.3M making its interest coverage ratio -5.5. It has cash and short-term investments of ₹4.2M.
Key information
0%
Debt to equity ratio
₹0
Debt
| Interest coverage ratio | -5.5x |
| Cash | ₹4.18m |
| Equity | ₹38.17m |
| Total liabilities | ₹3.44m |
| Total assets | ₹41.61m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 539206's short term assets (₹31.3M) exceed its short term liabilities (₹3.4M).
Long Term Liabilities: 539206's short term assets (₹31.3M) exceed its long term liabilities (₹1.8K).
Debt to Equity History and Analysis
Debt Level: 539206 is debt free.
Reducing Debt: 539206 has no debt compared to 5 years ago when its debt to equity ratio was 30.8%.
Debt Coverage: 539206 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 539206 has no debt, therefore coverage of interest payments is not a concern.